E. Lovati

发表

Netupitant, a Potent and Highly Selective NK1 Receptor Antagonist, Alleviates Acetic Acid-Induced Bladder Overactivity in Anesthetized Guinea-Pigs

S. Palea, C. Pietra, V. Guilloteau, 2016, Front. Pharmacol..

Profile of Antiemetic Activity of Netupitant Alone or in Combination with Palonosetron and Dexamethasone in Ferrets and Suncus murinus (House Musk Shrew)

G. Higgins, C. Giuliano, J. Rudd, 2016, Front. Pharmacol..

Activation of Neurokinin-1 Receptors Increases the Excitability of Guinea Pig Dorsal Root Ganglion Cells

W. D. de Groat, C. Pietra, Xiulin Zhang, 2012, Journal of Pharmacology and Experimental Therapeutics.

In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant

C. Giuliano, C. Ruzza, G. Calo’, 2015, Peptides.

The role of the 11β‐hydroxysteroid dehydrogenase type 2 in human hypertension

F. Frey, E. Lovati, P. Ferrari, 2000, Journal of hypertension.

Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors.

L. Cascione, A. Stathis, G. Damia, 2021, Blood advances.

Corrigendum: Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT3 Antagonist, Palonosetron and With the NK1 Antagonist, Netupitant, Against Cisplatin- and Motion-Induced Emesis in Suncus murinus (House Musk Shrew)

C. Giuliano, S. Chan, J. Rudd, 2018, Front. Pharmacol..

Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT3 Antagonist, Palonosetron and With the NK1 Antagonist, Netupitant, Against Cisplatin- and Motion-Induced Emesis in Suncus murinus (House Musk Shrew)

C. Giuliano, S. Chan, J. Rudd, 2018, Front. Pharmacol..

Effect of Tamoxifen in an Experimental Model of Breast Tumor Studied by Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Different Contrast Agents

Andrea Sbarbati, Pasquina Marzola, Elena Nicolato, 2005, Investigative radiology.

The brain‐penetrating, orally bioavailable, ghrelin receptor agonist HM01 ameliorates motion‐induced emesis in Suncus murinus (house musk shrew)

C. Giuliano, J. Rudd, C. Pietra, 2019, British journal of pharmacology.

Cortisol increases transfection efficiency of cells

F. Frey, A. Bernasconi, A. Rebuffat, 1997, FEBS letters.

Abstract 4784: TAS0286/HM05, a novel highly selective RET inhibitor, prominently inhibits various RET defective tumor growth

Masanori Kato, Y. Iwasawa, K. Matsuo, 2018, Experimental and Molecular Therapeutics.

MA13.05 TA0953/HM06, a Novel RET-specific Inhibitor Effective in Extracranial and CNS Disease Models of NSCLC with RETfusions

M. Ladanyi, R. Somwar, E. de Stanchina, 2022, Journal of Thoracic Oncology.

Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations

M. Ladanyi, R. Somwar, E. de Stanchina, 2023, Nature Cancer.